marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 10-30-2024
Intra-Cellular Therapies Balance Sheet 2011-2024 | ITCI
Annual Balance Sheet Intra-Cellular Therapies
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-131 M | -129 M | -67 M | - | -84.5 M | -54.9 M | -37.8 M | -48.6 M | -47.2 M | -61.3 M | 26.2 M | -19.1 M | - |
Long Term Debt |
13.3 M | 15.5 M | 18.7 M | - | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
3.61 M | 4.57 M | 6.73 M | 5.54 M | 3.19 M | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 20 M | 3.19 M | 2.84 M | 2.87 M | 1.6 M | - | - | - | - |
Total Current Liabilities |
124 M | 83.2 M | 53.4 M | 36.9 M | 36.2 M | 36.3 M | 14.2 M | 10.5 M | 6.26 M | 10.6 M | 6.83 M | - | - |
Total Liabilities |
137 M | 98.7 M | 72 M | 60.5 M | 56.2 M | 39.5 M | 17 M | 13.4 M | 7.86 M | 10.6 M | 26.2 K | 2.84 M | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | 1.67 M | - |
Retained Earnings |
-1.62 B | -1.48 B | -1.22 B | -937 M | -710 M | -562 M | -407 M | -309 M | -193 M | -88.3 M | -32.1 K | -30.7 M | - |
Total Assets |
728 M | 755 M | 490 M | 717 M | 251 M | 357 M | 471 M | 389 M | 484 M | 131 M | 4.07 K | 19.8 M | - |
Cash and Cash Equivalents |
148 M | 149 M | 92.4 M | 60 M | 108 M | 54.9 M | 37.8 M | 48.6 M | 47.2 M | 61.3 M | 35.2 M | 15.6 M | 13.7 M |
Book Value |
591 M | 656 M | 418 M | 657 M | 195 M | 318 M | 454 M | 376 M | 476 M | 121 M | -22.1 K | 17 M | - |
Total Shareholders Equity |
591 M | 656 M | 418 M | 657 M | 195 M | 318 M | 454 M | 376 M | 476 M | 121 M | 31.6 M | 17 M | 17.9 M |
All numbers in USD currency
Quarterly Balance Sheet Intra-Cellular Therapies
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
13.5 M | 14.1 M | 12.7 M | 13.3 M | 13.9 M | 14.4 M | 15 M | 15.5 M | 19.2 M | 19.1 M | 16.8 M | 18.7 M | 20.3 M | 21.7 M | 22.6 M | 23.6 M | 23.6 M | 23.6 M | 23.6 M | 20 M | 20 M | 20 M | 20 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.88 M | 2.91 M | 2.95 M | 2.87 M | 2.56 M | 2.87 M | 2.87 M | 1.6 M | - | 1.6 M | 1.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
180 M | 176 M | 148 M | 137 M | 117 M | 107 M | 94.5 M | 98.7 M | 96.6 M | 89.7 M | 75.8 M | 72 M | 70.2 M | 72.1 M | 62.3 M | 60.5 M | 60.5 M | 60.5 M | 60.5 M | 56.2 M | 56.2 M | 56.2 M | 56.2 M | 39.5 M | 39.5 M | 39.5 M | 39.5 M | 17 M | 17 M | 17 M | 17 M | 13.4 M | 13.4 M | 13.4 M | 13.4 M | 7.86 M | 7.86 M | 7.86 M | 7.86 M | 10.6 M | 10.6 M | 10.6 M | 10.6 M | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 417 K | - | - | 1.67 M | 1.67 M | - | - | - | - | - | - |
Retained Earnings |
-1.67 B | -1.65 B | -1.63 B | -1.62 B | -1.59 B | -1.56 B | -1.52 B | -1.48 B | -1.43 B | -1.38 B | -1.29 B | -1.22 B | -1.14 B | -1.06 B | -990 M | -937 M | -937 M | -937 M | -937 M | -710 M | -710 M | -710 M | -710 M | -562 M | -562 M | -562 M | -562 M | -407 M | -407 M | -407 M | -407 M | -309 M | -309 M | -309 M | -309 M | -193 M | -193 M | -193 M | -193 M | -88.3 M | -88.3 M | -88.3 M | -88.3 M | -57.6 M | -57.6 M | -57.6 M | -57.6 M | -30.7 M | -30.7 M | - | - | - | - | - | - |
Total Assets |
1.32 B | 1.32 B | 747 M | 728 M | 718 M | 714 M | 722 M | 755 M | 782 M | 812 M | 869 M | 490 M | 557 M | 626 M | 674 M | 717 M | 717 M | 717 M | 717 M | 251 M | 251 M | 251 M | 251 M | 357 M | 357 M | 357 M | 357 M | 471 M | 471 M | 471 M | 471 M | 389 M | 389 M | 389 M | 389 M | 484 M | 484 M | 484 M | 484 M | 131 M | 131 M | 131 M | 131 M | 38.4 M | 38.4 M | 38.4 M | 38.4 M | 19.8 M | 19.8 M | - | - | - | - | - | - |
Cash and Cash Equivalents |
464 M | 693 M | 140 M | 148 M | 99.4 M | 142 M | 75.7 M | 149 M | 135 M | 77.2 M | 129 M | 92.4 M | 106 M | 121 M | 130 M | 61.4 M | 60 M | 60 M | 60 M | 108 M | 108 M | 108 M | 108 M | 54.9 M | 54.9 M | 54.9 M | 54.9 M | 37.8 M | 37.8 M | 37.8 M | 37.8 M | 48.6 M | 48.6 M | 48.6 M | 48.6 M | 47.2 M | 47.2 M | 47.2 M | 47.2 M | 61.3 M | 61.3 M | 61.3 M | 61.3 M | 35.2 M | 35.2 M | 35.2 M | 35.2 M | 15.6 M | 15.6 M | - | - | 13.7 M | - | - | - |
Book Value |
1.14 B | 1.14 B | 599 M | 591 M | 601 M | 607 M | 628 M | 656 M | 685 M | 722 M | 793 M | 418 M | 487 M | 554 M | 612 M | 657 M | 657 M | 657 M | 657 M | 195 M | 195 M | 195 M | 195 M | 318 M | 318 M | 318 M | 318 M | 454 M | 454 M | 454 M | 454 M | 376 M | 376 M | 376 M | 376 M | 476 M | 476 M | 476 M | 476 M | 121 M | 121 M | 121 M | 121 M | 38.4 M | 38.4 M | 38.4 M | 38.4 M | 19.8 M | 19.8 M | - | - | - | - | - | - |
Total Shareholders Equity |
1.14 B | 1.14 B | 599 M | 591 M | 601 M | 607 M | 628 M | 656 M | 685 M | 722 M | 793 M | 418 M | 487 M | 554 M | 612 M | 657 M | 657 M | 657 M | 657 M | 195 M | 195 M | 195 M | 195 M | 318 M | 318 M | 318 M | 318 M | 454 M | 454 M | 454 M | 454 M | 376 M | 376 M | 376 M | 376 M | 476 M | 476 M | 476 M | 476 M | 121 M | 121 M | 121 M | 121 M | 31.6 M | 31.6 M | 31.6 M | 31.6 M | 17 M | 17 M | - | - | 17.9 M | - | - | - |
All numbers in USD currency